Pharma Journalist -

Orion Corporation and MSD announced a global development and commercialisation agreement for Orion’s investigational candidate ODM-208 and other drugs targeting cytochrome P450 11A1…
Read More...

Novavax, Inc. announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to…
Read More...

DNAnexus, Inc. and Twist Bioscience Corporation announced a collaboration aimed at accelerating research and reducing the time to design, validate, and commercialize new, high-quality,…
Read More...

AVROBIO, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for AVR-RD-05, its gene therapy for the treatment of mucopolysaccharidosis…
Read More...

Innoviva, Inc. announced that the company has entered into an agreement to sell its 15% economic stake in Theravance Respiratory Company LLC (“TRC”), which receives royalties stemming…
Read More...

Solvias announced that it has acquired Utrecht, Netherlands-based Cergentis. The acquisition bolsters Solvias' platform of biologics and cell and gene therapy (CGT) testing solutions.…
Read More...

Discovery Life Sciences (Discovery), the biospecimen and biomarker specialists, announced its acquisition of AllCells, a leading provider of clinical-grade (GMP-compliant) and Research…
Read More...

On the July 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and ACT Therapeutics (Seogkyoung-Kong, CEO), developing next-generation chimeric antigen receptor (CAR)-T…
Read More...

Bicycle Therapeutics plc announced that Genentech, a member of the Roche Group, has exercised its second option to initiate a new program, expanding the exclusive strategic…
Read More...

Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule therapeutics, announced that it has raised $50 million in a Series D financing round,…
Read More...